API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
60
PharmaCompass offers a list of Oxyquinoline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxyquinoline manufacturer or Oxyquinoline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxyquinoline manufacturer or Oxyquinoline supplier.
PharmaCompass also assists you with knowing the Oxyquinoline API Price utilized in the formulation of products. Oxyquinoline API Price is not always fixed or binding as the Oxyquinoline Price is obtained through a variety of data sources. The Oxyquinoline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxyquinoline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxyquinoline, including repackagers and relabelers. The FDA regulates Oxyquinoline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxyquinoline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oxyquinoline supplier is an individual or a company that provides Oxyquinoline active pharmaceutical ingredient (API) or Oxyquinoline finished formulations upon request. The Oxyquinoline suppliers may include Oxyquinoline API manufacturers, exporters, distributors and traders.
click here to find a list of Oxyquinoline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxyquinoline DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxyquinoline active pharmaceutical ingredient (API) in detail. Different forms of Oxyquinoline DMFs exist exist since differing nations have different regulations, such as Oxyquinoline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxyquinoline DMF submitted to regulatory agencies in the US is known as a USDMF. Oxyquinoline USDMF includes data on Oxyquinoline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxyquinoline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxyquinoline suppliers with USDMF on PharmaCompass.
A Oxyquinoline written confirmation (Oxyquinoline WC) is an official document issued by a regulatory agency to a Oxyquinoline manufacturer, verifying that the manufacturing facility of a Oxyquinoline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxyquinoline APIs or Oxyquinoline finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxyquinoline WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxyquinoline suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxyquinoline as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxyquinoline API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxyquinoline as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxyquinoline and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxyquinoline NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxyquinoline suppliers with NDC on PharmaCompass.
Oxyquinoline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxyquinoline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxyquinoline GMP manufacturer or Oxyquinoline GMP API supplier for your needs.
A Oxyquinoline CoA (Certificate of Analysis) is a formal document that attests to Oxyquinoline's compliance with Oxyquinoline specifications and serves as a tool for batch-level quality control.
Oxyquinoline CoA mostly includes findings from lab analyses of a specific batch. For each Oxyquinoline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxyquinoline may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxyquinoline EP), Oxyquinoline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxyquinoline USP).